CC
VYGR icon

Corton Capital’s Voyager Therapeutics VYGR Stock Holding History

Corton Capital’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,028
Closed -$187K – 666
2024
Q3 		$187K Buy
+32,028
New +$233K 0.09% 393
2023
Q3 		– Sell
-40,306
Closed -$462K – 543
2023
Q2 		$462K Buy
+40,306
New +$417K 0.22% 116
2023
Q1 		– Sell
-14,252
Closed -$86.9K – 391
2022
Q4 		$86.9K Buy
+14,252
New +$81K 0.07% 275

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corton Capital's VYGR Position: Q4 2024 in Review

Corton Capital sold out of Voyager Therapeutics (VYGR) in Q4 2024, closing a stake of 32,028 shares — an estimated $187K sold.

Corton Capital first reported a position in VYGR in Q4 2022 and held it in 3 quarters. The position peaked at $462K in Q2 2023. 132 funds tracked by Wall St. Rank hold VYGR as of Q4 2024.

  • Corton Capital reported no remaining Voyager Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 32,028 Voyager Therapeutics shares in Q4 2024, an estimated $187K.
  • Corton Capital first reported a position in Voyager Therapeutics in Q4 2022 and held it in 3 quarters.
  • Corton Capital's Voyager Therapeutics position peaked at $462K in Q2 2023.
  • 132 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.